Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

A national study of autogenous arteriovenous access use and patency in a contemporary hemodialysis population.

Stoumpos S, Traynor JP, Metcalfe W, Kasthuri R, Stevenson K, Mark PB, Kingsmore DB, Thomson PC.

J Vasc Surg. 2018 Dec 21. pii: S0741-5214(18)32483-2. doi: 10.1016/j.jvs.2018.10.063. [Epub ahead of print]

PMID:
30583903
2.

Author Correction: Lipid management in patients with chronic kidney disease.

Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C.

Nat Rev Nephrol. 2019 Feb;15(2):121. doi: 10.1038/s41581-018-0099-y.

PMID:
30538326
3.

Investigating the Relationship between Cerebral Blood Flow and Cognitive Function in Hemodialysis Patients.

Findlay MD, Dawson J, Dickie DA, Forbes KP, McGlynn D, Quinn T, Mark PB.

J Am Soc Nephrol. 2019 Jan;30(1):147-158. doi: 10.1681/ASN.2018050462. Epub 2018 Dec 7.

PMID:
30530658
4.

Vitamin K status, supplementation and vascular disease: a systematic review and meta-analysis.

Lees JS, Chapman FA, Witham MD, Jardine AG, Mark PB.

Heart. 2018 Dec 4. pii: heartjnl-2018-313955. doi: 10.1136/heartjnl-2018-313955. [Epub ahead of print]

PMID:
30514729
5.

Lipid management in patients with chronic kidney disease.

Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C.

Nat Rev Nephrol. 2018 Dec;14(12):727-749. doi: 10.1038/s41581-018-0072-9. Review. Erratum in: Nat Rev Nephrol. 2018 Dec 11;:.

PMID:
30361677
6.

The impact of coronary angiography on renal transplant function.

Lees JS, Findlay MD, Mark PB, Geddes CC.

QJM. 2019 Jan 1;112(1):23-27. doi: 10.1093/qjmed/hcy216.

PMID:
30295913
7.

Guidelines and clinical practice at the primary level of healthcare in patients with type 2 diabetes mellitus with and without kidney disease in five European countries.

Eder S, Leierer J, Kerschbaum J, Rosivall L, Wiecek A, de Zeeuw D, Mark PB, Heinze G, Rossing P, Heerspink HL, Mayer G.

Diab Vasc Dis Res. 2018 Sep 21:1479164118795559. doi: 10.1177/1479164118795559. [Epub ahead of print]

PMID:
30238781
8.

Inequality in Care and Differences in Outcome Following Stroke in People With ESRD.

Findlay MD, Dawson J, MacIsaac R, Jardine AG, MacLeod MJ, Metcalfe W, Traynor JP, Mark PB.

Kidney Int Rep. 2018 Apr 27;3(5):1064-1076. doi: 10.1016/j.ekir.2018.04.011. eCollection 2018 Sep.

9.

Interaction between socioeconomic deprivation and likelihood of pre-emptive transplantation: influence of competing risks and referral characteristics - a retrospective study.

Gillis KA, Lees JS, Ralston MR, Glen JA, Stevenson KS, McManus SK, Geddes CC, Clancy M, Traynor JP, Mark PB.

Transpl Int. 2019 Feb;32(2):153-162. doi: 10.1111/tri.13336. Epub 2018 Sep 21.

PMID:
30152890
10.

Magnetic resonance imaging biomarkers for chronic kidney disease: a position paper from the European Cooperation in Science and Technology Action PARENCHIMA.

Selby NM, Blankestijn PJ, Boor P, Combe C, Eckardt KU, Eikefjord E, Garcia-Fernandez N, Golay X, Gordon I, Grenier N, Hockings PD, Jensen JD, Joles JA, Kalra PA, Krämer BK, Mark PB, Mendichovszky IA, Nikolic O, Odudu A, Ong ACM, Ortiz A, Pruijm M, Remuzzi G, Rørvik J, de Seigneux S, Simms RJ, Slatinska J, Summers P, Taal MW, Thoeny HC, Vallée JP, Wolf M, Caroli A, Sourbron S.

Nephrol Dial Transplant. 2018 Sep 1;33(suppl_2):ii4-ii14. doi: 10.1093/ndt/gfy152.

11.

Ascorbic acid lowers central blood pressure and asymmetric dimethylarginine in chronic kidney disease.

Gillis K, Stevens KK, Bell E, Patel RK, Jardine AG, Morris STW, Schneider MP, Delles C, Mark PB.

Clin Kidney J. 2018 Aug;11(4):532-539. doi: 10.1093/ckj/sfx158. Epub 2018 Feb 6.

12.

Polygenic risk score as a determinant of risk of non-melanoma skin cancer in a European-descent renal transplant cohort.

Stapleton CP, Birdwell KA, McKnight AJ, Maxwell AP, Mark PB, Sanders ML, Chapman FA, van Setten J, Phelan PJ, Kennedy C, Jardine A, Traynor JP, Keating B, Conlon PJ, Cavalleri GL.

Am J Transplant. 2018 Aug 7. doi: 10.1111/ajt.15057. [Epub ahead of print]

PMID:
30085400
13.

Validation of Plasma Biomarker Candidates for the Prediction of eGFR Decline in Patients With Type 2 Diabetes.

Heinzel A, Kammer M, Mayer G, Reindl-Schwaighofer R, Hu K, Perco P, Eder S, Rosivall L, Mark PB, Ju W, Kretzler M, Gilmour P, Wilson JM, Duffin KL, Abdalla M, McCarthy MI, Heinze G, Heerspink HL, Wiecek A, Gomez MF, Oberbauer R; BEAt-DKD Consortium.

Diabetes Care. 2018 Sep;41(9):1947-1954. doi: 10.2337/dc18-0532. Epub 2018 Jul 6.

PMID:
29980527
14.

Risk Factors for Prognosis in Patients With Severely Decreased GFR.

Evans M, Grams ME, Sang Y, Astor BC, Blankestijn PJ, Brunskill NJ, Collins JF, Kalra PA, Kovesdy CP, Levin A, Mark PB, Moranne O, Rao P, Rios PG, Schneider MP, Shalev V, Zhang H, Chang AR, Gansevoort RT, Matsushita K, Zhang L, Eckardt KU, Hemmelgarn B, Wheeler DC.

Kidney Int Rep. 2018 Jan 11;3(3):625-637. doi: 10.1016/j.ekir.2018.01.002. eCollection 2018 May. Erratum in: Kidney Int Rep. 2018 Aug 30;3(6):1506.

15.

Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial.

Welsh P, Rankin N, Li Q, Mark PB, Würtz P, Ala-Korpela M, Marre M, Poulter N, Hamet P, Chalmers J, Woodward M, Sattar N.

Diabetologia. 2018 Jul;61(7):1581-1591. doi: 10.1007/s00125-018-4619-x. Epub 2018 May 4.

16.

Association of Total and Differential Leukocyte Counts With Cardiovascular Disease and Mortality in the UK Biobank.

Welsh C, Welsh P, Mark PB, Celis-Morales CA, Lewsey J, Gray SR, Lyall DM, Iliodromiti S, Gill JMR, Pell J, Jhund PS, Sattar N.

Arterioscler Thromb Vasc Biol. 2018 Jun;38(6):1415-1423. doi: 10.1161/ATVBAHA.118.310945. Epub 2018 Apr 26.

PMID:
29699973
17.

Characterizing Cardiac Involvement in Chronic Kidney Disease Using CMR-a Systematic Review.

Mangion K, McDowell K, Mark PB, Rutherford E.

Curr Cardiovasc Imaging Rep. 2018;11(1):2. doi: 10.1007/s12410-018-9441-9. Epub 2018 Jan 31. Review.

18.

A Prospective Cohort Study in Patients with Type 2 Diabetes Mellitus for Validation of Biomarkers (PROVALID) - Study Design and Baseline Characteristics.

Eder S, Leierer J, Kerschbaum J, Rosivall L, Wiecek A, de Zeeuw D, Mark PB, Heinze G, Rossing P, Heerspink HL, Mayer G.

Kidney Blood Press Res. 2018;43(1):181-190. doi: 10.1159/000487500. Epub 2018 Feb 16.

19.

Steroid regulation: An overlooked aspect of tolerance and chronic rejection in kidney transplantation.

Christakoudi S, Runglall M, Mobillo P, Rebollo-Mesa I, Tsui TL, Nova-Lamperti E, Norris S, Kamra Y, Hilton R, Bhandari S, Baker R, Berglund D, Carr S, Game D, Griffin S, Kalra PA, Lewis R, Mark PB, Marks SD, Macphee I, McKane W, Mohaupt MG, Pararajasingam R, Kon SP, Serón D, Sinha M, Tucker B, Viklický O, Lechler RI, Lord GM, Stahl D, Hernandez-Fuentes MP.

Mol Cell Endocrinol. 2018 Sep 15;473:205-216. doi: 10.1016/j.mce.2018.01.021. Epub 2018 Feb 7.

PMID:
29427591
20.

Long- and short-term outcomes in renal allografts with deceased donors: A large recipient and donor genome-wide association study.

Hernandez-Fuentes MP, Franklin C, Rebollo-Mesa I, Mollon J, Delaney F, Perucha E, Stapleton C, Borrows R, Byrne C, Cavalleri G, Clarke B, Clatworthy M, Feehally J, Fuggle S, Gagliano SA, Griffin S, Hammad A, Higgins R, Jardine A, Keogan M, Leach T, MacPhee I, Mark PB, Marsh J, Maxwell P, McKane W, McLean A, Newstead C, Augustine T, Phelan P, Powis S, Rowe P, Sheerin N, Solomon E, Stephens H, Thuraisingham R, Trembath R, Topham P, Vaughan R, Sacks SH, Conlon P, Opelz G, Soranzo N, Weale ME, Lord GM; United Kingdom and Ireland Renal Transplant Consortium (UKIRTC) and the Wellcome Trust Case Control Consortium (WTCCC)-3.

Am J Transplant. 2018 Jun;18(6):1370-1379. doi: 10.1111/ajt.14594. Epub 2018 Feb 1.

21.

Non-uniform relationship between salt status and aldosterone activity in patients with chronic kidney disease.

Taylor AHM, Rankin AJ, McQuarrie EP, Freel EM, Homer NZM, Andrew R, Jardine AG, Mark PB.

Clin Sci (Lond). 2018 Jan 25;132(2):285-294. doi: 10.1042/CS20171603. Print 2018 Jan 31.

PMID:
29321218
22.

Letter on 'European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis'.

Mark PB, Dekkers I, Blankestijn PJ, Leiner T, Roditi G.

J Eur Acad Dermatol Venereol. 2018 Feb;32(2):e84-e85. doi: 10.1111/jdv.14774. Epub 2018 Jan 23. No abstract available.

PMID:
29283443
23.

Strategies to manage cardiovascular risk in chronic kidney disease.

Mark PB.

Nephrol Dial Transplant. 2018 Jan 1;33(1):23-25. doi: 10.1093/ndt/gfx329. No abstract available.

PMID:
29237023
24.

The utility of anti-Müllerian hormone in women with chronic kidney disease, on haemodialysis and after kidney transplantation.

Stoumpos S, Lees J, Welsh P, Hund M, Geddes CC, Nelson SM, Mark PB.

Reprod Biomed Online. 2018 Feb;36(2):219-226. doi: 10.1016/j.rbmo.2017.11.003. Epub 2017 Nov 28.

PMID:
29233504
25.

Myocardial changes in incident haemodialysis patients over 6-months: an observational cardiac magnetic resonance imaging study.

Rutherford E, Mangion K, McComb C, Bell E, Cockburn S, Talle M, Roditi G, Welsh P, Woodward R, Radjenovic A, Struthers AD, Jardine AG, Berry C, Patel RK, Mark PB.

Sci Rep. 2017 Oct 25;7(1):13976. doi: 10.1038/s41598-017-14481-y.

26.

Renal replacement modality and stroke risk in end-stage renal disease-a national registry study.

Findlay M, MacIsaac R, MacLeod MJ, Metcalfe W, Traynor JP, Dawson J, Mark PB.

Nephrol Dial Transplant. 2017 Oct 24. doi: 10.1093/ndt/gfx291. [Epub ahead of print]

PMID:
29069522
27.

Blood pressure response to renal denervation is correlated with baseline blood pressure variability: a patient-level meta-analysis.

Persu A, Gordin D, Jacobs L, Thijs L, Bots ML, Spiering W, Miroslawska A, Spaak J, Rosa J, de Jong MR, Berra E, Fadl Elmula FEM, Wuerzner G, Taylor AHM, Olszanecka A, Czarnecka D, Mark PB, Burnier M, Renkin J, Kjeldsen SE, Widimský J, Elvan A, Kahan T, Steigen TK, Blankestijn PJ, Tikkanen I, Staessen JA; European Network COordinating research on Renal Denervation (ENCOReD).

J Hypertens. 2018 Feb;36(2):221-229. doi: 10.1097/HJH.0000000000001582.

PMID:
29045339
28.

New Model for Estimating Glomerular Filtration Rate in Patients With Cancer.

Janowitz T, Williams EH, Marshall A, Ainsworth N, Thomas PB, Sammut SJ, Shepherd S, White J, Mark PB, Lynch AG, Jodrell DI, Tavaré S, Earl H.

J Clin Oncol. 2017 Aug 20;35(24):2798-2805. doi: 10.1200/JCO.2017.72.7578. Epub 2017 Jul 7.

29.

Ferumoxytol-enhanced magnetic resonance angiography for the assessment of potential kidney transplant recipients.

Stoumpos S, Hennessy M, Vesey AT, Radjenovic A, Kasthuri R, Kingsmore DB, Mark PB, Roditi G.

Eur Radiol. 2018 Jan;28(1):115-123. doi: 10.1007/s00330-017-4934-5. Epub 2017 Jul 4.

30.

An Open-Label Dose-Finding Study of Allopurinol to Target Defined Reduction in Urate Levels in Hemodialysis Patients.

Rutherford E, Stewart G, Houston JG, Jardine AG, Mark PB, Struthers AD.

J Clin Pharmacol. 2017 Nov;57(11):1409-1414. doi: 10.1002/jcph.939. Epub 2017 Jun 9. No abstract available.

31.

Changes in Kidney Function in a Population With Essential Hypertension in Real Life Settings.

Ptinopoulou AG, Pikilidou MI, Tziolas IM, Haidich AB, Mark PB, Zebekakis PE, Lasaridis AN.

Iran J Kidney Dis. 2017 May;11(3):192-200.

32.

Renal association clinical practice guideline in post-operative care in the kidney transplant recipient.

Baker RJ, Mark PB, Patel RK, Stevens KK, Palmer N.

BMC Nephrol. 2017 Jun 2;18(1):174. doi: 10.1186/s12882-017-0553-2.

33.

What happens to the heart in chronic kidney disease?

Rutherford E, Mark PB.

J R Coll Physicians Edinb. 2017 Mar;47(1):76-82. doi: 10.4997/JRCPE.2017.117. Review.

PMID:
28569289
34.

Reduced and declining physical function in prevalent dialysis patients-identifying the vulnerable.

Findlay MD, Mark PB.

Age Ageing. 2017 Jul 1;46(4):541-543. doi: 10.1093/ageing/afx049. No abstract available.

PMID:
28407065
35.

Continued monitoring of acute kidney injury survivors might not be necessary in those regaining an estimated glomerular filtration rate >60 mL/min at 1 year.

Stoumpos S, Mark PB, McQuarrie EP, Traynor JP, Geddes CC.

Nephrol Dial Transplant. 2017 Jan 1;32(1):81-88. doi: 10.1093/ndt/gfw413.

PMID:
28391314
36.

Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH).

Sarafidis PA, Persu A, Agarwal R, Burnier M, de Leeuw P, Ferro CJ, Halimi JM, Heine GH, Jadoul M, Jarraya F, Kanbay M, Mallamaci F, Mark PB, Ortiz A, Parati G, Pontremoli R, Rossignol P, Ruilope L, Van der Niepen P, Vanholder R, Verhaar MC, Wiecek A, Wuerzner G, London GM, Zoccali C.

Nephrol Dial Transplant. 2017 Apr 1;32(4):620-640. doi: 10.1093/ndt/gfw433. Review.

PMID:
28340239
37.

Uric Acid and Decline in Renal Function-Partners in Crime.

Dawson J, Mark PB.

Am J Nephrol. 2017;45(4):327-329. doi: 10.1159/000464261. Epub 2017 Mar 11. No abstract available.

38.

Renal artery and parenchymal changes after renal denervation: assessment by magnetic resonance angiography.

Sanders MF, van Doormaal PJ, Beeftink MMA, Bots ML, Fadl Elmula FEM, Habets J, Hammer F, Hoffmann P, Jacobs L, Mark PB, Persu A, Renkin J, Roditi G, Spiering W, Staessen JA, Taylor AH, Verloop WL, Vink EE, Vonken EJ, Voskuil M, Leiner T, Blankestijn PJ; European Network COordinating research on Renal Denervation (ENCOReD) Consortium.

Eur Radiol. 2017 Sep;27(9):3934-3941. doi: 10.1007/s00330-017-4770-7. Epub 2017 Mar 7.

39.

Native T1 mapping: inter-study, inter-observer and inter-center reproducibility in hemodialysis patients.

Graham-Brown MP, Rutherford E, Levelt E, March DS, Churchward DR, Stensel DJ, McComb C, Mangion K, Cockburn S, Berry C, Moon JC, Mark PB, Burton JO, McCann GP.

J Cardiovasc Magn Reson. 2017 Feb 27;19(1):21. doi: 10.1186/s12968-017-0337-7.

40.

Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH).

Sarafidis PA, Persu A, Agarwal R, Burnier M, de Leeuw P, Ferro C, Halimi JM, Heine G, Jadoul M, Jarraya F, Kanbay M, Mallamaci F, Mark PB, Ortiz A, Parati G, Pontremoli R, Rossignol P, Ruilope L, Van der Niepen P, Vanholder R, Verharr MC, Wiecek A, Wuerzner G, London GM, Zoccali C.

J Hypertens. 2017 Apr;35(4):657-676. doi: 10.1097/HJH.0000000000001283.

PMID:
28157814
41.

Predictors of atherosclerotic events in patients on haemodialysis: post hoc analyses from the AURORA study.

Solbu MD, Mjøen G, Mark PB, Holdaas H, Fellström B, Schmieder RE, Zannad F, Herrington WG, Jardine AG.

Nephrol Dial Transplant. 2018 Jan 1;33(1):102-112. doi: 10.1093/ndt/gfw360.

PMID:
27798199
42.

Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis.

Currie G, Taylor AH, Fujita T, Ohtsu H, Lindhardt M, Rossing P, Boesby L, Edwards NC, Ferro CJ, Townend JN, van den Meiracker AH, Saklayen MG, Oveisi S, Jardine AG, Delles C, Preiss DJ, Mark PB.

BMC Nephrol. 2016 Sep 8;17(1):127. doi: 10.1186/s12882-016-0337-0. Review.

43.

Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping.

Rutherford E, Talle MA, Mangion K, Bell E, Rauhalammi SM, Roditi G, McComb C, Radjenovic A, Welsh P, Woodward R, Struthers AD, Jardine AG, Patel RK, Berry C, Mark PB.

Kidney Int. 2016 Oct;90(4):845-52. doi: 10.1016/j.kint.2016.06.014. Epub 2016 Aug 5.

44.

Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials.

Cholesterol Treatment Trialists' (CTT) Collaboration, Herrington WG, Emberson J, Mihaylova B, Blackwell L, Reith C, Solbu MD, Mark PB, Fellström B, Jardine AG, Wanner C, Holdaas H, Fulcher J, Haynes R, Landray MJ, Keech A, Simes J, Collins R, Baigent C.

Lancet Diabetes Endocrinol. 2016 Oct;4(10):829-39. doi: 10.1016/S2213-8587(16)30156-5. Epub 2016 Jul 29.

45.

Deleterious effects of phosphate on vascular and endothelial function via disruption to the nitric oxide pathway.

Stevens KK, Denby L, Patel RK, Mark PB, Kettlewell S, Smith GL, Clancy MJ, Delles C, Jardine AG.

Nephrol Dial Transplant. 2017 Oct 1;32(10):1617-1627. doi: 10.1093/ndt/gfw252.

46.

Non-Contrast Renal Magnetic Resonance Imaging to Assess Perfusion and Corticomedullary Differentiation in Health and Chronic Kidney Disease.

Gillis KA, McComb C, Patel RK, Stevens KK, Schneider MP, Radjenovic A, Morris ST, Roditi GH, Delles C, Mark PB.

Nephron. 2016;133(3):183-92. doi: 10.1159/000447601. Epub 2016 Jul 1.

PMID:
27362585
47.

Biomarkers of Tolerance in Kidney Transplantation: Are We Predicting Tolerance or Response to Immunosuppressive Treatment?

Rebollo-Mesa I, Nova-Lamperti E, Mobillo P, Runglall M, Christakoudi S, Norris S, Smallcombe N, Kamra Y, Hilton R; Indices of Tolerance EU Consortium, Bhandari S, Baker R, Berglund D, Carr S, Game D, Griffin S, Kalra PA, Lewis R, Mark PB, Marks S, Macphee I, McKane W, Mohaupt MG, Pararajasingam R, Kon SP, Serón D, Sinha MD, Tucker B, Viklický O, Lechler RI, Lord GM, Hernandez-Fuentes MP.

Am J Transplant. 2016 Dec;16(12):3443-3457. doi: 10.1111/ajt.13932. Epub 2016 Aug 8.

48.

Risk factors and outcome of stroke in renal transplant recipients.

Findlay MD, Thomson PC, MacIsaac R, Jardine AG, Patel RK, Stevens KK, Rutherford E, Clancy M, Geddes CC, Dawson J, Mark PB.

Clin Transplant. 2016 Aug;30(8):918-24. doi: 10.1111/ctr.12765. Epub 2016 Jun 21.

PMID:
27218240
49.

What does STOP-IgAN tell us about how to treat IgA nephropathy?

Rutherford E, Mark PB.

J R Coll Physicians Edinb. 2016 Mar;46(1):23-5. doi: 10.4997/JRCPE.2016.107. No abstract available.

PMID:
27092366
50.

Research cardiac magnetic resonance imaging in end stage renal disease - incidence, significance and implications of unexpected incidental findings.

Rutherford E, Weir-McCall JR, Patel RK, Houston JG, Roditi G, Struthers AD, Jardine AG, Mark PB.

Eur Radiol. 2017 Jan;27(1):315-324. Epub 2016 Apr 7.

Supplemental Content

Support Center